7 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of Treatment ... Agents for COVID ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management
COVID-19 review…here is a list of some of the drugs that are currently being used or
of some of the drugs ... here are the 4 drug ... #Management #Pandemic ... Pharmacotherapy #Pharmacology ... #CriticalCare #
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology ... #alternatives #Drugs
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
anti-parasitic agent ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
agents benefits ... tolerable • High MIC ... • Therapeutic drug ... #valleyfever #management ... #treatment #antifungals
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... Weaknesses: High MIC ... Weaknesses: Therapeutic drug ... Coccidioidomycosis #pharmacology ... #management #treatment
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
A dissociative drug ... non-OTC prolonging agent ... No pharmacologic ... #CriticalCare # ... diagnosis #management